Chimeric inhibitor molecules of complement activation
US-9815876-B2 · Nov 14, 2017 · US
US9701733B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9701733-B2 |
| Application number | US-201414445772-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2014 |
| Priority date | May 24, 2011 |
| Publication date | Jul 11, 2017 |
| Grant date | Jul 11, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides maspin-related compositions and methods of use thereof. In particular, the present invention provides maspin-related compositions, and methods or use thereof, for the promotion of cell adhesion.
Opening claim text (preview).
What is claimed is: 1. A method of enhancing cell adhesion comprising administering to a cell, tissue, or subject a composition comprising a therapeutically effective amount of a peptide or polypeptide that comprises a portion with at least 90% sequence identity with one or more of SEQ ID NO:1, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:7, wherein the peptide or polypeptide is not full-length mapsin. 2. The method of claim 1 , wherein enhancing cell adhesion resul…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.